Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ebenezer Oloyede

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Epidemiology and Psychiatric Sciences|November 25, 2022
Clozapine haematological monitoring for neutropenia: a global perspectiveEbenezer Oloyede, Graham Blackman, Eromona Whiskey, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 20, 2022
Clozapine-induced myocarditis: electronic health register analysis of incidence, timing, clinical markers and diagnostic accuracyAviv Segev, Ehtesham Iqbal, Theresa A McDonagh, et al.
The Lancet. Psychiatry|April 10, 2026
Clozapine rechallenge after neutropenia: a retrospective cohort study in the UKEbenezer Oloyede, Olubanke Dzahini, James MacCabe, et al.
Schizophrenia (Heidelberg, Germany)|October 31, 2025
Low awareness of clozapine-induced agranulocytosis in a mixed-method survey of 354 patients and carersEbenezer Oloyede, Von-de-Viel Nettey, Olubanke Dzahini, et al.
BMC Psychiatry|October 14, 2021
Benign ethnic neutropenia: an analysis of prevalence, timing and identification accuracy in two large inner-city NHS hospitalsEbenezer Oloyede, Olubanke Dzahini, Nigel Barnes, et al.
Schizophrenia Bulletin|August 26, 2025
Late-Onset Neutropenia in Clozapine Users: Unrelated or Drug-Induced? A Case-Registry Analysis of Incidence, Characteristics, and Rechallenge AttemptsAviv Segev, Risha Govind, Ebenezer Oloyede, et al.
Therapeutic Advances in Psychopharmacology|January 5, 2023
Clozapine for treatment resistance in early psychosis: a survey of UK clinicians' training, knowledge and confidenceEbenezer Oloyede, Bethany Mantell, Julie Williams, et al.
The British Journal of Psychiatry : the Journal of Mental Science|August 16, 2024
Identifying clinically relevant agranulocytosis in people registered on the UK clozapine Central Non-Rechallenge Database: retrospective cohort studyEbenezer Oloyede, Christian J Bachmann, Olubanke Dzahini, et al.
Schizophrenia Bulletin|February 5, 2021
There Is Life After the UK Clozapine Central Non-Rechallenge DatabaseEbenezer Oloyede, Cecilia Casetta, Olubanke Dzahini, et al.
The Lancet. Psychiatry|June 30, 2022
Relaxation of the criteria for entry to the UK Clozapine Central Non-Rechallenge Database: a modelling studyEbenezer Oloyede, Eromona Whiskey, Cecilia Casetta, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Epidemiology and Psychiatric Sciences|November 25, 2022
Clozapine haematological monitoring for neutropenia: a global perspectiveEbenezer Oloyede, Graham Blackman, Eromona Whiskey, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 20, 2022
Clozapine-induced myocarditis: electronic health register analysis of incidence, timing, clinical markers and diagnostic accuracyAviv Segev, Ehtesham Iqbal, Theresa A McDonagh, et al.
The Lancet. Psychiatry|April 10, 2026
Clozapine rechallenge after neutropenia: a retrospective cohort study in the UKEbenezer Oloyede, Olubanke Dzahini, James MacCabe, et al.
Schizophrenia (Heidelberg, Germany)|October 31, 2025
Low awareness of clozapine-induced agranulocytosis in a mixed-method survey of 354 patients and carersEbenezer Oloyede, Von-de-Viel Nettey, Olubanke Dzahini, et al.
BMC Psychiatry|October 14, 2021
Benign ethnic neutropenia: an analysis of prevalence, timing and identification accuracy in two large inner-city NHS hospitalsEbenezer Oloyede, Olubanke Dzahini, Nigel Barnes, et al.
Schizophrenia Bulletin|August 26, 2025
Late-Onset Neutropenia in Clozapine Users: Unrelated or Drug-Induced? A Case-Registry Analysis of Incidence, Characteristics, and Rechallenge AttemptsAviv Segev, Risha Govind, Ebenezer Oloyede, et al.
Therapeutic Advances in Psychopharmacology|January 5, 2023
Clozapine for treatment resistance in early psychosis: a survey of UK clinicians' training, knowledge and confidenceEbenezer Oloyede, Bethany Mantell, Julie Williams, et al.
The British Journal of Psychiatry : the Journal of Mental Science|August 16, 2024
Identifying clinically relevant agranulocytosis in people registered on the UK clozapine Central Non-Rechallenge Database: retrospective cohort studyEbenezer Oloyede, Christian J Bachmann, Olubanke Dzahini, et al.
Schizophrenia Bulletin|February 5, 2021
There Is Life After the UK Clozapine Central Non-Rechallenge DatabaseEbenezer Oloyede, Cecilia Casetta, Olubanke Dzahini, et al.
The Lancet. Psychiatry|June 30, 2022
Relaxation of the criteria for entry to the UK Clozapine Central Non-Rechallenge Database: a modelling studyEbenezer Oloyede, Eromona Whiskey, Cecilia Casetta, et al.
Pageof 4